Reports Fri Oct 30Before openConfirmed
Seven straight quarters of EPS beats go on the line at 6:00 AM ET, with consensus at $0.47 a share. Anything merely in line would break the pattern investors have been paying up for.
Companies
/Healthcare
BrightSpring Health Services Inc
$67.15
▲ $1.29 (+1.96%) today
Markets closed · 11:17am ET
BTSG at a Glance
Valuation
- Market cap
- $13.4B
- P/E ratio
- 47.6
Profitability
- Revenue (TTM)
- $15.3B
- Profit margin
- 2.7%
- EPS (TTM)
- $1.41
Price
- 52-week range
- $31 – $74
- Street target
- $83.21
Headquartered in Louisville, KY Fiscal year ends December NASDAQ: BTSG brightspringhealth.com
About BrightSpring Health Services
BrightSpring Health Services (NASDAQ: BTSG) provides home- and community-based health services for medically complex populations that need specialized and/or chronic care. It operates in all 50 states and serves approximately 500,000 customers, clients and patients daily.
The company reports two segments:
- **Pharmacy Solutions** is its largest revenue contributor. It dispenses roughly 11 million prescriptions per quarter through pharmacy services that include specialty and infusion offerings.
- **Provider Services** includes Home Health Care, Rehab Care (rehabilitation services) and Personal Care.
In March 2026, BrightSpring divested its Community Living business to focus on pharmacy and home health. It has expanded home health through the acquisition of Amedisys and LHC branches.
Revenue is driven largely by Medicare, Medicaid, managed care and Part D reimbursement. KKR is a significant stockholder. Updated
Frequently Asked Questions
What does BrightSpring Health Services do?
BrightSpring Health Services (NASDAQ: BTSG) provides home- and community-based health services for medically complex populations that need specialized and/or chronic care. It operates in all 50 states and serves approximately 500,000 customers, clients and patients daily.
What is the BTSG stock price target?
The Wall Street consensus 12-month price target for BTSG is $83.21.